Stira Pharmaceuticals is a U.S.-based CDMO specializing in the development and cGMP manufacture of complex sterile injectable products, with integrated analytical capabilities. Founded in 2019, the company serves the U.S. market with services spanning small molecules, peptides, oligonucleotides, and biosimilars in formats including vials, syringes, IV bags, and cartridges with batch sizes up to 2,000L.
complex sterile injectables, contract analytical services, peptide analytics, oligonucleotide analytics, biosimilar analytical testing, in vitro testing (IVPT/IVRT)
1 site worldwide
Involvement in 14 clinical trials
No reviews available yet.
No documents available.